Skip to content
  • Sunday, 26 July 2026
  • 1:45 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Buck Institute Study Reveals How APOE2 Gene Protects Against Alzheimer’s and Promotes Longevity through DNA Repair and Senescence Resistance
Neuroscience & Brain Research

Buck Institute Study Reveals How APOE2 Gene Protects Against Alzheimer’s and Promotes Longevity through DNA Repair and Senescence Resistance

Rifan Muazin Jul 24, 2026 0

For decades, the genetic landscape of Alzheimer’s disease has been dominated by the study of the apolipoprotein E (APOE) gene.…

Read More
Neuroscience & Brain Research

Extensive Washington State University Research Reveals How Cannabis Intoxication Distorts Multiple Memory Systems and Promotes False Recollections

Rifan Muazin Mar 20, 2026 0

The conventional understanding of cannabis use often centers on the "fuzzy" or "hazy" feeling reported by users, but a comprehensive…

Read More
Unveiling Earth’s Hidden Infrastructure: First Global Maps Reveal the Vast Scale of Underground Fungal Networks Crucial for Climate RegulationWHO introduces faster, more accessible TB testing strategies while CDC maintains a targeted, risk-based approach in the United States.Low-frequency vector electrometry with a Rydberg dipolar chainTavapadon Poised for Competitive Parkinson’s Disease Market Following Promising Tremor Data
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ